Literature DB >> 33079230

Gaps between research and recommendations in rheumatoid arthritis.

Ana María Ortiz1, Lucía Silva Fernández2, Virginia Villaverde3, Miguel Ángel Abad4, José Ramón Maneiro5, Gloria Candelas6, Susana Gómez7, Mónica Valderrama7, María Montoro7.   

Abstract

OBJECTIVES: To identify recommendations on the diagnosis and management of rheumatoid arthritis (RA) supported by low recommendation grades, to study the causes of this low grading, and to propose solutions.
METHODS: A group of six rheumatologists, with extensive experience in the development of systematic reviews, reviewed national and international RA recommendations and practice guidelines. They identified all recommendations with a low level of evidence or recommendation grade (levels equivalent to 4, 5, or grades C or D of the Oxford Levels of Evidence), classified them by areas (diagnosis, follow-up, treatment, others), and analyzed plausible causes of low graduation. A Delphi was used to select 10 recommendations where it was most important to obtain quality evidence to support them. Subsequently, actions were proposed to improve evidence and recommendation grading.
RESULTS: Fourteen documents were analyzed, in which 192 recommendations with low evidence/grade of recommendation were identified, most of which were on treatment. The two most frequent causes of this low level are the absence of studies and the discrepancy between the wording of the recommendation and the evidence used. Finally, the proposed solution to the critical recommendations is a list of unanswered research questions and possible designs to answer them.
CONCLUSIONS: We propose to design and promote research that truly supports or rectifies clinical practice and, thus, bridges the gap between existing evidence and critical recommendations.

Entities:  

Keywords:  Clinical practice guidelines; Level of evidence; Recommendations; Rheumatoid arthritis; Systematic review

Year:  2020        PMID: 33079230     DOI: 10.1007/s00296-020-04724-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  18 in total

1.  Using PICO and the brief report to answer clinical questions.

Authors:  Mary Y Elkins
Journal:  Nursing       Date:  2010-04

2.  Using PICO to align medical evidence with MDs decision making models.

Authors:  Dympna O'Sullivan; Szymon Wilk; Wojtek Michalowski; Ken Farion
Journal:  Stud Health Technol Inform       Date:  2013

Review 3.  Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: scientific evidence and expert opinion.

Authors:  María A Martín-Martínez; Carlos González-Juanatey; Santos Castañeda; Javier Llorca; Iván Ferraz-Amaro; Benjamín Fernández-Gutiérrez; Federico Díaz-González; Miguel A González-Gay
Journal:  Semin Arthritis Rheum       Date:  2014-01-24       Impact factor: 5.532

4.  2016 update of the EULAR recommendations for the management of early arthritis.

Authors:  Bernard Combe; Robert Landewe; Claire I Daien; Charlotte Hua; Daniel Aletaha; Jose María Álvaro-Gracia; Margôt Bakkers; Nina Brodin; Gerd R Burmester; Catalin Codreanu; Richard Conway; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Joao Fonseca; Karim Raza; Lucía Silva-Fernández; Josef S Smolen; Diana Skingle; Zoltan Szekanecz; Tore K Kvien; Annette van der Helm-van Mil; Ronald van Vollenhoven
Journal:  Ann Rheum Dis       Date:  2016-12-15       Impact factor: 19.103

5.  2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis.

Authors:  Raimon Sanmartí; Susana García-Rodríguez; José María Álvaro-Gracia; José Luis Andreu; Alejandro Balsa; Rafael Cáliz; Antonio Fernández-Nebro; Iván Ferraz-Amaro; Juan Jesús Gómez-Reino; Isidoro González-Álvaro; Emilio Martín-Mola; Víctor Manuel Martínez-Taboada; Ana M Ortiz; Jesús Tornero; Sara Marsal; José Vicente Moreno-Muelas
Journal:  Reumatol Clin       Date:  2015-06-06

Review 6.  EULAR recommendations for patient education for people with inflammatory arthritis.

Authors:  Heidi A Zangi; Mwidimi Ndosi; Jo Adams; Lena Andersen; Christina Bode; Carina Boström; Yvonne van Eijk-Hustings; Laure Gossec; Jana Korandová; Gabriel Mendes; Karin Niedermann; Jette Primdahl; Michaela Stoffer; Marieke Voshaar; Astrid van Tubergen
Journal:  Ann Rheum Dis       Date:  2015-03-03       Impact factor: 19.103

Review 7.  EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.

Authors:  R Agca; S C Heslinga; S Rollefstad; M Heslinga; I B McInnes; M J L Peters; T K Kvien; M Dougados; H Radner; F Atzeni; J Primdahl; A Södergren; S Wallberg Jonsson; J van Rompay; C Zabalan; T R Pedersen; L Jacobsson; K de Vlam; M A Gonzalez-Gay; A G Semb; G D Kitas; Y M Smulders; Z Szekanecz; N Sattar; D P M Symmons; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2016-10-03       Impact factor: 19.103

8.  EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis.

Authors:  Alexandra N Colebatch; Christopher John Edwards; Mikkel Østergaard; Désirée van der Heijde; Peter V Balint; Maria-Antonietta D'Agostino; Kristina Forslind; Walter Grassi; Espen A Haavardsholm; Glenn Haugeberg; Anne-Grethe Jurik; Robert B M Landewé; Esperanza Naredo; Philip J O'Connor; Ben Ostendorf; Kristina Potocki; Wolfgang A Schmidt; Josef S Smolen; Sekib Sokolovic; Iain Watt; Philip G Conaghan
Journal:  Ann Rheum Dis       Date:  2013-03-21       Impact factor: 19.103

Review 9.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.

Authors:  Josef S Smolen; Robert Landewé; Johannes Bijlsma; Gerd Burmester; Katerina Chatzidionysiou; Maxime Dougados; Jackie Nam; Sofia Ramiro; Marieke Voshaar; Ronald van Vollenhoven; Daniel Aletaha; Martin Aringer; Maarten Boers; Chris D Buckley; Frank Buttgereit; Vivian Bykerk; Mario Cardiel; Bernard Combe; Maurizio Cutolo; Yvonne van Eijk-Hustings; Paul Emery; Axel Finckh; Cem Gabay; Juan Gomez-Reino; Laure Gossec; Jacques-Eric Gottenberg; Johanna M W Hazes; Tom Huizinga; Meghna Jani; Dmitry Karateev; Marios Kouloumas; Tore Kvien; Zhanguo Li; Xavier Mariette; Iain McInnes; Eduardo Mysler; Peter Nash; Karel Pavelka; Gyula Poór; Christophe Richez; Piet van Riel; Andrea Rubbert-Roth; Kenneth Saag; Jose da Silva; Tanja Stamm; Tsutomu Takeuchi; René Westhovens; Maarten de Wit; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2017-03-06       Impact factor: 19.103

10.  Can evidence-based medicine and clinical quality improvement learn from each other?

Authors:  Paul Glasziou; Greg Ogrinc; Steve Goodman
Journal:  BMJ Qual Saf       Date:  2011-04       Impact factor: 7.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.